Amygdala Inhibitory Neuron Dysfunction in Schizophrenia | Neuroscience Seminar

Added:

The Aberrant Salience and Dopamine Hypothesis of Schizophrenia

While focusing on amygdala inhibitory neuron dysfunction highlights localized microcircuit deficits, a prominent alternative framework is the Dopamine Hypothesis and the concept of Aberrant Salience. This perspective argues that the core pathophysiology of schizophrenia is driven by hyperdopaminergic activity in the striatum, rather than primary amygdala pathology. According to this view, dopamine dysregulation leads to the inappropriate assignment of motivational significance (salience) to neutral internal and external stimuli, which subsequently gives rise to delusions and hallucinations. Critics of localized amygdala-centric models suggest that amygdala dysfunction may be a downstream consequence of this broader dopaminergic dysregulation and altered cortical-subcortical connectivity, rather than the primary etiological driver. Furthermore, critics point out that translating genetic mouse models of inhibitory microcircuits to human clinical outcomes is highly challenging, as these rodent models cannot adequately capture the complex, subjective experiences of human psychosis.

Anatomy and functional role of the amygdala in emotional processing, threat detection, and social behavior.
Fundamentals of synaptic transmission, specifically the distinction between excitatory (glutamatergic) and inhibitory (GABAergic) signaling.
The clinical presentation and neurobiological hypotheses of schizophrenia, including positive, negative, and cognitive symptoms.
The methodology of using transgenic and knockout genetic mouse models to mimic human psychiatric disorders in laboratory settings.
Targeted pharmacological interventions, such as specific GABA receptor modulators, designed to restore inhibitory control in the amygdala.
The Excitation/Inhibition (E/I) imbalance theory of schizophrenia and its manifestations in other key brain regions like the prefrontal cortex.
Advanced neuromodulation techniques (e.g., optogenetics and DREADDs) used to selectively control and study interneuron excitability in vivo.
Translational biomarkers (such as EEG gamma oscillations or functional MRI connectivity) that bridge rodent model findings with clinical observations in human patients.
377 views6likes58:50@faujupiter4909Original Release: 2020-10-07

This lecture presents research demonstrating that dysfunction in amygdala inhibitory circuits, particularly involving neurexin-1 alpha and ErbB4 signaling pathways, contributes to amygdala disinhibition as a common endophenotype in schizophrenia spectrum disorders. The research uses multiple mouse models to show that both neurexin-1 alpha knockout mice and ErbB4 intercalated cell knockout mice exhibit impaired fear learning, social interaction deficits, and disrupted synaptic plasticity in amygdala circuits, suggesting that targeting amygdala intercalated cells may offer therapeutic potential for treating schizophrenia.